Accendra Health Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Accendra Health stock have an average target of 3.38, with a low estimate of 2.75 and a high estimate of 4.00. The average target predicts an increase of 39.67% from the current stock price of 2.42.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.75	$3.38	$4.00	$4.00
Change	+13.64%	+39.67%	+65.29%	+65.29%

Analyst Ratings

The average analyst rating for Accendra Health stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	0	0	0	1	1
Buy	0	0	0	0	0
Hold	1	1	1	0	1
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	1	1	1	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Cherny Leerink Partners	Leerink Partners	Hold Maintains $3 → $2.75	Hold	Maintains	$3 → $2.75	+13.64%	Feb 20, 2026
Daniel Grosslight Citigroup	Citigroup	Strong Buy Maintains $7 → $4	Strong Buy	Maintains	$7 → $4	+65.29%	Jan 9, 2026
Trina Chen Goldman Sachs	Goldman Sachs	Strong Sell → Hold Upgrades n/a	Strong Sell → Hold	Upgrades	n/a	n/a	Aug 25, 2022
David Chang Macquarie	Macquarie	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Jan 3, 2020

More Analyst Ratings

Financial Forecast

Revenue This Year

2.63B

from 2.76B

-4.78%

from 2.76B

Revenue Next Year

2.78B

from 2.63B

5.55%

from 2.63B

EPS This Year

0.95

from -14.32

EPS Next Year

1.19

from 0.95

25.29%

from 0.95

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	9.79B	9.96B	2.55B	2.68B	2.76B	2.63B	2.78B
Revenue Growth	15.39%	1.74%	-74.36%	5.00%	3.06%	-4.78%	5.55%
EPS	2.94	0.29	-0.54	-4.73	-14.32	0.95	1.19
EPS Growth	523.69%	-90.14%	-	-	-	-	25.29%
Forward PE	-	-	-	-	-	2.56	2.04
No. Analysts	-	-	-	-	-	7	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	2.8B	3.0B
Avg	2.6B	2.8B
Low	2.5B	2.5B

Revenue Growth

Revenue Growth	2026	2027
High	2.8%	13.5%
Avg	-4.8%	5.6%
Low	-10.1%	-4.4%

EPS Forecast

EPS	2026	2027
High	1.05	1.38
Avg	0.95	1.19
Low	0.80	1.02

EPS Growth

EPS Growth	2026	2027
High	-	45.3%
Avg	-	25.3%
Low	-	7.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.